Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophages

Biochemical and Biophysical Research Communications

Volumn 431, Issue 2, 2013, Pages 124-130

  Kinoshita, Hiroyuki ^a   Matsumura, Takeshi ^a   Ishii, Norio ^a   Fukuda, Kazuki ^a   Senokuchi, Takafumi ^a   Motoshima, Hiroyuki ^a   Kondo, Tatsuya ^a   Taketa, Kayo ^a   Kawasaki, Shuji ^a   Hanatani, Satoko ^a   Takeya, Motohiro ^a   Nishikawa, Takeshi ^a   Araki, Eiichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Apocynin; Atherosclerosis; Macrophages; NADPH oxidase; Reactive oxygen species

Indexed keywords

4 HYDROXYNONENAL; APOCYNIN; APOLIPOPROTEIN E; CYCLINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETOPHENONES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHEMOKINE CCL2; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERLEUKIN-6; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, MUTANT STRAINS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

MUS;

EID: 84873458260     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.014     Document Type: Article

References (35)

1. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
2. Schachinger V., Zeiher A.M. Atherogenesis-recent insights into basicmechanisms and their clinical impact. Nephrol. Dial. Transplant. 2002, 17:2055-2064.
3. Simons J.M., Hart B.A., IpVaiChing T.R., Van Dijk H., Labadie R.P. Metabolic activation of natural phenols into selective oxidative burstagonists by activated human neutrophils. Free Radic. Biol. Med. 1990, 8:251-258.
4. Hart T.B.A., Simons J.M., Knaan-Shanzer S., Bakker N.P., Labadie R.P. Antiarthritic activity of the newly developed neutrophil oxidativeburst antagonist apocynin. Free Radic. Biol. Med. 1990, 9:127-131.
5. Weber C., Erl W., Pietsch A., Strobel M., Ziegler-Heitbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclearfactor-kappa B mobilization and induction of vascular cell adhesionmolecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 1994, 14:1665-1673.
6. Muller A.A., Reiter S.A., Heider K.G., Wagner H. Plant-derivedacetophenones with antiasthmatic and anti-inflammatory properties: inhibitoryeffects on chemotaxis, right angle light scatter and actin polymerizationof polymorphonuclear granulocytes. Planta Med. 1999, 65:590-594.
7. Muijsers R.B., van Den Worm E., Folkerts G., Beukelman C.J., Koster A.S., D.S.Postma, Nijkamp F.P. Apocynin inhibits peroxynitriteformation by murine macrophages. Br. J. Pharmacol. 2000, 130:932-936.
8. Barbieri S.S., Cavalca V., Eligini S., Brambilla M., Caiani A., Tremoli E., Colli S. Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic. Biol. Med. 2004, 37:156-165.
9. Stolk J., Hiltermann T.J., Dijkman J.H., Verhoeven A.J. Characteristicsof the inhibition of NADPH oxidase activation in neutrophils by apocynin, amethoxy-substituted catechol. Am. J. Respir. Cell. Mol. Biol. 1994, 11:95-102.
10. Griendling K.K., Sorescu D., Ushio Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 2000, 86:494-501.
11. Bokoch M., Knaus U.G. NADPH oxidases: not just for leukocytes anymore!. Trends Biochem. Sci. 2003, 28:502-508.
12. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., Valppu L., Quinn M.T., Lambeth J.D., Vega J.D., Taylor W.R., Griendling K.K. Superoxide production and expression of nox family proteins in humanatherosclerosis. Circulation 2002, 105:1429-1435.
13. Drummond G.R., Selemidis S., Griendling K.K., Sobey C.G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug. Discov. 2011, 10:453-471.
14. Matsumura T., Kinoshita H., Ishii N., Fukuda K., Motoshima H., Senokuchi T., Taketa K., Kawasaki S., Nishimaki-Mogami T., Kawada T., Nishikawa T., Araki E. Telmisartan exerts anti-atherosclerotic effects by activating PPARγ in macrophages. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1268-1275.
15. Matsumura T., Sakai M., Kobori S., Biwa T., Takemura T., Matsuda H., Hakamata H., Horiuchi S., Shichiri M. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler. Thromb. Vasc. Biol. 1997, 17:3013-3020.
16. Chodakewitz J.A., Kupper T.S., Coleman D.L. Keratinocyte-derived granulocyte/macrophage colony-stimulating factor induces DNA synthesis by peritoneal macrophages. J. Immunol. 1998, 140:832-836.
17. Munker R., Gasson J., Ogawa M., Koeffler H.P. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 1986, 323:79-82.
18. Yano M., Matsumura T., Senokuchi T., Ishii N., Motoshima H., Taguchi T., Matsuo T., Sonoda K., Kukidome D., Sakai M., Kawada T., Nishikawa T., Araki E. Thiazolidinediones inhibit oxidized low density lipoprotein-induced macrophage proliferation. Atherosclerosis 2007, 191:22-32.
19. Matsumura T., Sakai M., Matsuda K., Furukawa N., Kaneko K., Shichiri M. Cis-acting DNA elements of mouse granulocyte/macrophage colony-stimulating factor gene responsive to oxidized low density lipoprotein. J. Biol. Chem. 1999, 274:37665-37672.
20. Senokuchi T., Matsumura T., Sakai M., Matsuo T., Yano M., Kiritoshi S., Sonoda K., Kukidome D., Nishikawa T., Araki E. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis 2004, 176:233-245.
21. Dzau V.J., Braun-Dullaeus R.C., Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 2002, 8:1249-1256.
22. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 1996, 20:707-727.
23. Shackelford R.E., Kaufmann W.K., Paules R.S. Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med. 2000, 28:1387-1404.
24. Mueller C.F., Laude K., McNally J.S., Harrison D.G. ATVB in focus: redox mechanismsin blood vessels. Arterioscler. Thromb. Vasc. Biol. 2005, 25:274-278.
25. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:29-38.
26. Galle J., Hansen-Hagge T., Wanner C., Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006, 185:219-226.
27. Nguyen-Khoa R., Massy Z., Witko-Sarsat V., Canteloup S., Kebebe M., Lacour B., Drüecke T., Descamps-Latscha B. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: a novel pathway in atherogenesis?. Biochem. Biophys. Res. Commun. 1999, 263:804-809.
28. Fischer B., von Knethen A., Brüne B. Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-γ. J. Immunol. 2002, 168:2828-2834.
29. Rosenfeld M.E., Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990, 10:680-687.
30. Spagnoli L.G., Orlandi A., Santeusanio G. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis 1991, 88:87-92.
31. Gordon D., Reidy M.A., Benditt E.P., Schwartz S.M. Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. USA 1990, 87:4600-4604.
32. Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 1994, 269:31430-31435.
33. Martens J.S., Reiner N.E., Herrera-Velit P., Steinbrecher U.P. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein. J. Biol. Chem. 1998, 273:4915-4920.
34. Hamilton J.A., Myers D., Jessup W., Cochrane F., Byrne R., Whitty G., Moss S. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 1999, 19:98-105.
35. Biwa T., Hakamata H., Sakai M., Miyazaki A., Suzuki H., Kodama T., Shichiri M., Horiuchi S. Induction of murine macrophage growth by oxidized low-density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 1998, 273:28305-28313.